<DOC>
	<DOCNO>NCT01502878</DOCNO>
	<brief_summary>Nut sensitization skin prick test common area , include Finland , birch pollen abundant . However , sensitization nut skin prick test predict possibility allergic symptom nuts ingest . In study investigator launch perform double-blind placebo-controlled nut challenge oral desensitization/ protocol serious symptom challenge . The efficacy safety new oral desensitization program primary outcome . The effect oral desensitization bronchial hyperreactivity , eosinophilic airway inflammation , quality life secondary outcome .</brief_summary>
	<brief_title>Nut Allergy Study : Double-blind Challenge Oral Desensitization</brief_title>
	<detailed_description>The investigator aim improve nut allergy diagnosis launch new double-blind placebo-controlled nut ( peanut , hazel nut , cashew ) challenge protocol . The investigator also launch specific oral tolerance induction ( SOTI ) protocol nuts serious nut allergy . This study take place Helsinki University Skin Allergy Hospital May 2011 December 2015 . Inclusion criterion : age 6 18 year suspect nut allergy ( unclear anaphylaxis possibly cause nut , skin prick test nut ≥ 10 mm specific-IgE ≥ 20 kU/L never eat nut , avoids nut dare try nut home ) . Patients uncontrolled asthma lung disease , cardiovascular disease systemic disease , use beta-blockers , poor compliance , exclude . Methods : The investigator perform skin prick test peanut , tree nut seed , take blood sample double-blind placebo-controlled food challenge ( DBPCFC ) , measure total IgE specific-IgE birch , peanut , hazel nut , allergen component Ara h 1 , 2 , 3 , 8 , Cor 1 8 . Then serum sample keep frozen component immunologic analysis . The investigator put iv challenge . In DBPCFC patient receive 5 mg , 50 mg , 200mg , 1000mg nut protein mixt placebo , placebo every 30 minute . The severity allergic reaction estimate use modify severity scale . The probability severe/moderate reaction low ( &lt; 0.7 kU/L ) increase ( &gt; 0.7 kU/L ) Ara h 2 8 concentration primary end-point DBPCFC . The investigator also correlate concentration Ara h 2 severity score . Patients moderate severe reaction challenge offer desensitization therapy `` SOTI '' use ( pea ) nut flour mixed milk-free margarine . The first dose 0.1 mg nut protein give hospital part up-dosing make home every 2 week . The patient take antihistamine 1 hour daily dose . An epinephrine autoinjector prednisolone tablet also prescribe emergency use . The desensitization protocol take 28 week personalize need . Exercise avoid 1 hour follow dose . Before SOTI investigator measure food relate quality life use standardized questionnaire , perform metacholine challenge measure exhale nitric oxid . After SOTI investigator take blood sample perform DBPCFC .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Nut Hypersensitivity</mesh_term>
	<criteria>sensitization skin prick test serum nutspecific IgE unknown anaphylaxis suspect cause nut never eat nut challenge positive serious symptom , OIT active asthma low lung function , pregnancy , cardiovascular disease might worsen challenge OIT</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Nut allergy</keyword>
	<keyword>Double-blind placebo-controlled ( DBPC ) oral nut challenge</keyword>
	<keyword>Nut oral immunotherapy ( OIT )</keyword>
	<keyword>Nut oral desensitization</keyword>
</DOC>